Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | CROWN PHARMACEUTICALSLikely | 6 | ₹360 |
| 2 | Schedule 2 | CROWN PHARMACEUTICALSLikely | 5 | ₹35,904 |
| 3 | Schedule 3 | SUKUN PHARMALikely | 4 | ₹13,848 |
| 4 | Schedule 4 | SUKUN PHARMALikely | 7 | ₹4,536 |
| 5 | Schedule 5 | CROWN PHARMACEUTICALSLikely | 3 | ₹4,304.40 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
27 Jun 2026, 2:00 pmClosed
rd 122
9474894
GEM/2026/B/7670177
Two Packet Bid
Ropinirole 0 point 5mg Tab,Sevelamer Carbonate Sachet 800mg,Rizatriptan 5 mg Tab,Mebeverine HCL 135
Udhampur, Jammu And Kashmir
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹1 L
₹3 L
30%
Exempted
Yes
27 Jun 2026
16 Jun 2026
27 Jun 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Ropinirole 0 point 5mg Tab | as per specification | 2,400 | No | UDHAMPUR | 30 |
| 2 | Sevelamer Carbonate Sachet 800mg | as per specification | 9,600 | No | UDHAMPUR | 30 |
| 3 | Rizatriptan 5 mg Tab | as per specification | 2,400 | No | UDHAMPUR | 30 |
| 4 | Mebeverine HCL 135mg Tab | as per specification | 3,600 | No | UDHAMPUR | 30 |
| 5 | Frusemide 40mg Tab | as per specification | 12,660 | No | UDHAMPUR | 30 |
| 6 | Levodopa 100 mg plus Carbidopa 25mg Tab | as per specification | 22,800 | No | UDHAMPUR | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9474894.pdf
GEM_BID • 0.14 MB
rd122_2026-06-16-13-24-45_1c3c32854272caadf6ef3435f5d21f8e.pdf
BOQ • 0.19 MB
122_2026-06-16-13-24-45_f646476657aa4b4dab679460394565bc.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .